Nothing Special   »   [go: up one dir, main page]

Kim et al., 2022 - Google Patents

Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

Kim et al., 2022

View HTML @Full View
Document ID
14746500483225071937
Author
Kim D
Tu K
Wei A
Lau A
Gonzalez-Gil A
Cao T
Braunstein K
Ling J
Troncoso J
Wong P
Blackshaw S
Schnaar R
Li T
Publication year
Publication venue
Molecular neurodegeneration

External Links

Snippet

Background Amongst risk alleles associated with late-onset Alzheimer's disease (AD), those that converged on the regulation of microglia activity have emerged as central to disease progression. Yet, how canonical amyloid-β (Aβ) and tau pathologies regulate microglia …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Kim et al. Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes
Lall et al. C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Mrdjen et al. The basis of cellular and regional vulnerability in Alzheimer’s disease
Nakanishi et al. Functional significance of rare neuroligin 1 variants found in autism
Polito et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB
Shao et al. Genetics of Alzheimer’s disease: From pathogenesis to clinical usage
Askanas et al. Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy
Jan et al. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
Cox et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS)
Sawa et al. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Lim et al. Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease
Arai Significance and limitation of the pathological classification of TDP‐43 proteinopathy
Mizuno et al. MUTYH actively contributes to microglial activation and impaired neurogenesis in the pathogenesis of Alzheimer’s disease
Runge et al. Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons
Liang et al. Microglia and its Genetics in Alzheimer's Disease
Hendrickx et al. A new synuclein-transgenic mouse model for early Parkinson’s reveals molecular features of preclinical disease
Miao et al. SARM1 promotes neurodegeneration and memory impairment in mouse models of Alzheimer's disease
Ziaei et al. Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult
Strong et al. Amyotrophic lateral sclerosis, primary lateral sclerosis and spinal muscular atrophy
Pan et al. Osteoblastic Swedish mutant APP expedites brain deficits by inducing endoplasmic reticulum stress-driven senescence
Whitney et al. Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy
Ikeda et al. Pick's disease with neuronal four‐repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum
Bartoletti-Stella et al. Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases
Tran et al. APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology
CN113151432A (en) Novel targets for neurodegenerative disease detection and treatment